Adiponectin measures indicate pain severity, study suggests

03/21/2013 | MedPage Today (free registration)

A small study that included 20 women with migraines found that adiponectin measures could predict pain severity and treatment response, Johns Hopkins University researchers reported in the journal Headache. Ratios of high-to-low molecular weight adiponectin could be tied to severity of pain, indicating the potential for use as a migraine biomarker and drug target.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ